Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Helius Medical Technologies Inc. HSDT

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:HSDT)

Fundamentals Snapshot (NDAQ:HSDT)

Current News (NDAQ:HSDT)

Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022

GlobeNewswire 11 days ago

Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023

GlobeNewswire January 19, 2023

Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program

GlobeNewswire January 10, 2023

Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis

GlobeNewswire January 5, 2023

Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk

GlobeNewswire January 3, 2023

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire December 30, 2022

Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results

GlobeNewswire November 14, 2022

Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program

GlobeNewswire November 9, 2022

Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

GlobeNewswire November 8, 2022

Bullboard Posts (NDAQ:HSDT)

Where's prokofiev?

29 cents now after the reverse split LMAO. Down 99.92% since inception in 2014. I guess the arrogant dipsh1t who names himself after a...
daviekin - September 30, 2022

HSDT.....don't go to bed empty handed ; )

Ya pays yo money and yo takes yo chances Cheers !
Iseneschal - September 15, 2022

HSDT...... Here's another to take a close look at!

Anything inder 60 cents is good in my opinion Do your own DD  Cheers !   Helius Medical Technologies to Present at...
Iseneschal - September 9, 2022

RE:HSDT .... Words of Wisdom ?

What did I tell .....HSDT was at $0.495.....Now Mr. Maggot is "high closing" this Beotch Cheap paper makes the world go...
Iseneschal - September 1, 2022

HSDT .... Words of Wisdom ?

Be a Buyer when the Markets are trading to the downside..... Be a Seller when the Markets are trading to the upside. When you feel...
Iseneschal - September 1, 2022

HSDT...so far..so good. Now expect the unexpected because...

My targets are going to be reached.... JMHO They are....... $0.59.....$0.63....a break of $0.73 and we're into "The Gap"...
Iseneschal - August 30, 2022